Metabolic Syndromes and Cardiovascular Disease: What is on the horizon?

Anwar Santoso

Abstract


Metabolic syndrome (MetS) is characterised by the simultaneous occurrence of at least three out of five
cardio-metabolic disorders.1, 2 These problems consist of visceral obesity, hypertension, high blood glucose, high
triglyceride, and low HDL cholesterol levels.2 It is unclear to what extent communities with diverse ethnic
backgrounds differ in the contributing factors. Additionally, the risk of cardio-vascular disease (CVD) mortality
may vary depending on the frequency of MetS and its components in various ethnic groups and nations.3 Inappropriately,
information on the CVD mortality risk associated with MetS is still quite limited, especially in Asian
countries. The majority of investigations were limited to determining the prevalence of MetS and its contributing
variables among Asians. Due mostly to unhealthy lifestyle such as an imbalanced diet high in carbohydrate and
sedentary habits, the prevalence of MetS has been rising along with urbanisation.4


Keywords


Cardiovascular disease; Metabolic syndrome.

Full Text:

PDF

References


Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 Oct 25; 112(17): 2735 – 52.

Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman PI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 Oct 20; 120(16): 1640-5.

Liu L, Miura K, Fujiyoshi A, et al. Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan. Am J Cardiol 2014; 113: 84-9.

Jia P. Obesogenic environment and childhood obesity. Obesit Rev Offic J Int Assoc Study Obesity 2021; 22: 13158. Doi: 10.1111/obr.13158.

O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obesity Rev. 2015; 16: 1-12. Doi: 10.1111/obr.12229.

Cheong KC, Lim KH, Ghazali SM, The CH, Cheah YK, Baharudin A, et al. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study. BMJ Open 2021; 11: e047849. Doi: 10.1136/bmjopen-2020-047849.

Li X, Wang Q, Feng C, Yu B, Lin X, Fu Y, et al. Associations and pathways between residential greenness and metabolic syndromes in Fujian Province. Front Public Health 2022; 10: 80. Doi: 10.3389/fpubh.2022.1014380.

Sigit FA, Tahapary DL, Trompet S, Sartono E, van Dijk KW, Rosendaal FR, et al. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies. Diabetol Metab Syndr 2020; 12: 2 https://doi.org/10.1186/s13098-019-0503-1.

Araneta MRG, Wingard DL, Barret-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women; a high-risk non-obese population. Diabetes Care 2002; 25(3): 494-9.

Leskinen T, Suorsa K, Heinonen IHA, Loyttyniemi E, Pentti J, Vahtera J, et al. The Effect of Commercial Activity Tracker Based Physical Activity Intervention on Body Composition and cardiometabolic Health Among Recent Retirees. Front Aging 2021; 2: 757080. Doi: 10.3389/fragi.2021.757080.

Mousavi AM, Ejtahed H-S, Marvasti FE, Taghavi M, Siadat SD, Hasani-Ranjbar S, et al. The Effect of a Moderately Restricted Cardohydrate Diet on Cardiometabolic Risk Factors in Overweight and Obese Women With Metabolic Syndrome: A Randomized Controlled Trial. Clin Ther 2023 Mar; 45(3): e103-e114. Doi: 10.1016/jclinthera.2023.02.002. Epub 2023 mar 4.

Gadde KM, Martin CK, Berthoud H-R, Heymsfield SB. Obesity. Pathophysiology and Management. J Am Coll Cardiol 2018; 71: 69-84.




DOI: https://doi.org/10.21776/ub.hsj.2023.004.03.1

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Anwar Santoso

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.